EPO Biomarkers Market
According to Intent Market Research, the EPO Biomarkers Market is expected to grow from USD 56.2 billion in 2023 at a CAGR of 5.9% to touch USD 83.7 billion by 2030. The EPO Biomarkers Market is dominated by key players such as AbbVie, Roche Diagnostics, Thermo Fisher Scientific, Novartis, Amgen Inc., Eli Lilly and Co., Merck & Co., Inc., Bristol Myers Squibb, Abbott Laboratories, Siemens Healthineers, Johnson & Johnson, Genentech, Medtronic, Bio-Rad Laboratories, Inc., BD (Becton, Dickinson and Company)